Invention Grant
- Patent Title: Aerosolized fluoroquinolones and uses thereof
- Patent Title (中): 气雾化氟喹诺酮类及其用途
-
Application No.: US12604347Application Date: 2009-10-22
-
Publication No.: US08524735B2Publication Date: 2013-09-03
- Inventor: Mark W. Surber , Keith A. Bostian , Michael N. Dudley , Olga Lomovskaya , David C. Griffith
- Applicant: Mark W. Surber , Keith A. Bostian , Michael N. Dudley , Olga Lomovskaya , David C. Griffith
- Applicant Address: US NJ Bridgewater
- Assignee: MPEX Pharmaceuticals, Inc.
- Current Assignee: MPEX Pharmaceuticals, Inc.
- Current Assignee Address: US NJ Bridgewater
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61K31/44 ; A61K31/4412 ; A61K33/00 ; A61K33/06 ; A61K33/14 ; A61K33/26 ; A61K33/30 ; A01N25/00 ; A01N25/02 ; A01N25/06 ; A01N59/08
Abstract:
Disclosed herein are formulations of fluoroquinolones suitable for aerosolization and use of such formulations for aerosol administration of fluoroquinolone antimicrobials for the treatment of pulmonary bacterial infections. In particular, inhaled levofloxacin specifically formulated and delivered for bacterial infections of the lungs is described. Methods include inhalation protocols and manufacturing procedures for production and use of the compositions described.
Public/Granted literature
- US20100037890A1 AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF Public/Granted day:2010-02-18
Information query
